Ignite Creation Date:
2025-12-24 @ 3:22 PM
Ignite Modification Date:
2025-12-26 @ 10:42 AM
Study NCT ID:
NCT06840392
Status:
RECRUITING
Last Update Posted:
2025-10-31
First Post:
2025-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24'}, 'conditionBrowseModule': {'meshes': [{'id': 'D017497', 'term': 'Hidradenitis Suppurativa'}, {'id': 'D016575', 'term': 'Hidradenitis'}, {'id': 'D003872', 'term': 'Dermatitis'}], 'ancestors': [{'id': 'D017192', 'term': 'Skin Diseases, Bacterial'}, {'id': 'D001424', 'term': 'Bacterial Infections'}, {'id': 'D001423', 'term': 'Bacterial Infections and Mycoses'}, {'id': 'D007239', 'term': 'Infections'}, {'id': 'D012874', 'term': 'Skin Diseases, Infectious'}, {'id': 'D013492', 'term': 'Suppuration'}, {'id': 'D012871', 'term': 'Skin Diseases'}, {'id': 'D017437', 'term': 'Skin and Connective Tissue Diseases'}, {'id': 'D013543', 'term': 'Sweat Gland Diseases'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'C000722911', 'term': 'remibrutinib'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 555}}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2025-03-20', 'type': 'ACTUAL'}, 'statusVerifiedDate': '2025-10', 'completionDateStruct': {'date': '2028-10-20', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2025-10-30', 'studyFirstSubmitDate': '2025-02-17', 'studyFirstSubmitQcDate': '2025-02-17', 'lastUpdatePostDateStruct': {'date': '2025-10-31', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2025-02-21', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2028-06-02', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Proportion of participants with Hidradenitis Suppurativa clinical response 50 (HiSCR50) at Week 16', 'timeFrame': 'Week 16', 'description': 'HiSCR50 is defined as at least a 50% decrease in Abscess and Inflammatory Nodule (AN) count with no increase in the number of abscesses and in the number of draining tunnels/fistulae compared to baseline.'}], 'secondaryOutcomes': [{'measure': 'Proportion of participants with Abscesses and inflammatory nodules 50 (AN50) response at Week 16', 'timeFrame': 'Week 16', 'description': 'AN50 is defined as at least a 50% decrease in Abscess and Inflammatory Nodule (AN) count compared to baseline'}, {'measure': 'Percentage change from baseline in International Hidradenitis Suppurativa Severity Score System (IHS4) at Week 16', 'timeFrame': 'From baseline up to Week 16', 'description': 'The IHS4 is a disease severity scoring system developed by the European Hidradenitis Suppurativa Foundation. It is a weighted sum of different types of inflammatory lesion counts, calculated as 1 x number of nodules + 2 x number of abscesses + 4 x number of draining tunnels (=fistulae=sinuses).'}, {'measure': 'Proportion of participants with HiSCR75 response at Week 16', 'timeFrame': 'Week 16', 'description': 'HiSCR75 is defined as at least a 75% decrease in Abscess and Inflammatory Nodule (AN) count with no increase in the number of abscesses and in the number of draining tunnels/fistulae compared to baseline.'}, {'measure': 'Proportion of participants experiencing Hidradenitis Suppurativa (HS) flares at Week 16', 'timeFrame': 'Up to Week 16', 'description': 'Flare is defined as at least a 25% increase in AN count with a minimum increase of 2 AN relative to baseline.'}, {'measure': 'Proportion of participants with HiSCR50 response at Week 8', 'timeFrame': 'Week 8', 'description': 'HiSCR50 is defined as at least a 50% decrease in Abscess and Inflammatory Nodule (AN) count with no increase in the number of abscesses and in the number of draining tunnels/fistulae compared to baseline.'}, {'measure': 'Proportion of participants with HiSCR90 response at Week 16', 'timeFrame': 'Week 16', 'description': 'HiSCR90 is defined as at least a 90% decrease in Abscess and Inflammatory Nodule (AN) count with no increase in the number of abscesses and in the number of draining tunnels/fistulae compared to baseline.'}, {'measure': 'Proportion of participants with clinical response in HS related skin pain (NRS 30), at worst at Week 16', 'timeFrame': 'Week 16', 'description': "Achievement of NRS30 at Week 16, among participants with baseline NRS ≥ 3 (pooled data from studies CLOU064J12301 and CLOU064J12302).\n\nNRS30 is defined as at least a 30% reduction and at least 2-unit reduction from baseline in Patient's Global Assessment of Skin Pain - at worst over the past 7 days."}, {'measure': 'Incidence of treatment emergent adverse events and serious adverse events during the study', 'timeFrame': 'From randomization to end of study, assessed up to 72 weeks.', 'description': 'The distribution of adverse events will be done via the analysis of frequencies for treatment emergent Adverse Event (TEAEs), Serious Adverse Event (TESAEs) and Deaths due to AEs, through the monitoring of relevant clinical and laboratory safety parameters.'}]}, 'oversightModule': {'oversightHasDmc': True, 'isFdaRegulatedDrug': True, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ["Bruton's tyrosine kinase (BTK) inhibitor", 'Hidradenitis Suppurativa', 'HS', 'Hidradenitis Suppurativa clinical response', 'HiSCR', 'remibrutinib', 'LOU064', 'Hidradenitides, Suppurativa', 'Hidradenitis, Suppurativa', 'Suppurativa Hidradenitides', 'Suppurativa Hidradenitis', 'Acne inversa,', 'Verneuil disease', 'Inflammatory skin disease', 'Chronic skin condition'], 'conditions': ['Hidradenitis Suppurativa']}, 'descriptionModule': {'briefSummary': 'The purpose of this study is to establish the efficacy, safety, and tolerability of remibrutinib (LOU064) Dose A and Dose B compared to placebo in participants with moderate to severe hidradenitis suppurativa (HS).', 'detailedDescription': 'The total duration of the study is 76 weeks and consists of: Screening (up to 4 weeks), Treatment Period 1 (16 weeks, double-blind treatment with remibrutinib (Dose A or Dose B) or placebo, Treatment Period 2 (52 weeks, treatment with remibrutinib (Dose A or Dose B) and Safety Follow-Up (treatment-free follow-up for 4 weeks).\n\nParticipants who prematurely discontinue study treatment (either during Treatment Period 1 or Treatment Period 2) are encouraged to remain in the study. Participants who do not wish to remain in the study will enter a 4-week Safety Follow-Up period.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'maximumAge': '100 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': "Key Inclusion Criteria:\n\n1. Male and female participants ≥ 18 years of age at the time of signing of the informed consent.\n2. Diagnosis of HS based on clinical history and physical examination for at least 6 months prior to the Baseline visit.\n3. Participants with moderate to severe HS defined as:\n\n * A total of at least 5 AN count (abscesses and/or inflammatory nodules) AND\n * Inflammatory lesions should affect at least 2 distinct anatomic areas (e.g., left and right axillae)\n\nKey Exclusion Criteria:\n\n1. Presence of more than 20 fistulae/tunnels (both draining and non-draining) in total at baseline.\n2. Any active skin disease or conditions that may interfere with the assessment of HS.\n3. Previous exposure to remibrutinib or other BTK inhibitors.\n4. Use of other investigational drugs within 5 half-lives of enrollment, or within 30 days (for small molecules) prior to randomization, or until the pharmacodynamic effect has returned to baseline (for biologics), whichever is longer.\n5. Significant bleeding risk or coagulation disorders.\n6. History of gastrointestinal bleeding.\n7. Requirement for anti-platelet (except for acetylsalicylic acid up to 100 mg/d or clopidogrel up to 75 mg/d) or anti-coagulant medication.\n8. History or current hepatic disease.\n9. Evidence of clinically significant cardiovascular, neurological, psychiatric, pulmonary, renal, hepatic, endocrine, metabolic, hematological disorders, gastrointestinal disease or immunodeficiency that, in the Investigator's opinion, would compromise the safety of the participant, interfere with the interpretation of the study results or otherwise preclude participation or protocol adherence of the participant.\n10. History of hypersensitivity to any of the study drug constituents.\n11. Known or suspected infectious disease that is active, chronic or recurrent which precludes the participant from participating in the trial as per investigator's assessment. These infectious diseases include and are not limited to opportunistic infections (e.g., tuberculosis, atypical mycobacterioses, listeriosis or aspergillosis) and/or known or suspected Human Immunodeficiency Virus (HIV) infection. Should it be required by local regulations and/or considered appropriate by the investigator, an HIV test can be performed to confirm eligibility.\n12. History of live attenuated vaccine administration within 6 weeks prior to randomization or requirement to receive these vaccinations at any time while on study treatment.\n13. Major surgery within 8 weeks prior to screening or planned surgery for the duration of the study.\n\nOther protocol-defined inclusion/exclusion criteria may apply."}, 'identificationModule': {'nctId': 'NCT06840392', 'acronym': 'RECHARGE 2', 'briefTitle': 'Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult Patients With Moderate to Severe Hidradenitis Suppurativa', 'organization': {'class': 'INDUSTRY', 'fullName': 'Novartis'}, 'officialTitle': 'A Randomized, Double-blind, Double-dummy, Placebo-controlled, Multicenter, Phase 3 Study Assessing the Efficacy, Safety, and Tolerability of 2 Doses of Remibrutinib Over a 68-week Treatment Period in Adult Patients With Moderate to Severe Hidradenitis Suppurativa', 'orgStudyIdInfo': {'id': 'CLOU064J12302'}, 'secondaryIdInfos': [{'id': '2024-513266-19-00', 'type': 'REGISTRY', 'domain': 'EU CT Number'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'EXPERIMENTAL', 'label': 'Remibrutinib Dose A (Treatment Period 1 and 2)', 'description': 'articipants randomized to receive remibrutinib Dose A during Treatment Period 1 and 2', 'interventionNames': ['Drug: Remibrutinib Dose A']}, {'type': 'EXPERIMENTAL', 'label': 'Remibrutinib Dose B (Treatment Period 1 and 2)', 'description': 'Participants randomized to receive remibrutinib Dose B during Treatment Period 1 and 2', 'interventionNames': ['Drug: Remibrutinib Dose B']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo (Treatment Period 1) + remibrutinib Dose B (Treatment Period 2)', 'description': 'Participants randomized to receive placebo during Treatment Period 1 followed by remibrutinib dose B during Treatment Period 2', 'interventionNames': ['Drug: Remibrutinib Dose B', 'Drug: Placebo 1', 'Drug: Placebo 2']}], 'interventions': [{'name': 'Remibrutinib Dose A', 'type': 'DRUG', 'otherNames': ['LOU064'], 'description': 'Remibrutinib Dose A (oral)', 'armGroupLabels': ['Remibrutinib Dose A (Treatment Period 1 and 2)']}, {'name': 'Remibrutinib Dose B', 'type': 'DRUG', 'otherNames': ['LOU064'], 'description': 'Remibrutinib Dose B (oral)', 'armGroupLabels': ['Placebo (Treatment Period 1) + remibrutinib Dose B (Treatment Period 2)', 'Remibrutinib Dose B (Treatment Period 1 and 2)']}, {'name': 'Placebo 1', 'type': 'DRUG', 'description': 'Placebo matching to remibrutinib Dose A (oral)', 'armGroupLabels': ['Placebo (Treatment Period 1) + remibrutinib Dose B (Treatment Period 2)']}, {'name': 'Placebo 2', 'type': 'DRUG', 'description': 'Placebo matching to remibrutinib Dose B (oral)', 'armGroupLabels': ['Placebo (Treatment Period 1) + remibrutinib Dose B (Treatment Period 2)']}]}, 'contactsLocationsModule': {'locations': [{'zip': '35205', 'city': 'Birmingham', 'state': 'Alabama', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Angela Powell', 'role': 'CONTACT', 'email': 'angela@totalskinandbeauty.com'}, {'name': 'Rajini Murthy', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Total Skin and Beauty Dermatology Center PC', 'geoPoint': {'lat': 33.52066, 'lon': -86.80249}}, {'zip': '85234', 'city': 'Gilbert', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jesus Tomasi', 'role': 'CONTACT', 'email': 'jesus.tomasi@avacare.com', 'phone': '+1 801 528 9503'}, {'name': 'Lori Kuuipo Eiko Ramirez', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'CTT Research', 'geoPoint': {'lat': 33.35283, 'lon': -111.78903}}, {'zip': '85260', 'city': 'Scottsdale', 'state': 'Arizona', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Martina Montero', 'role': 'CONTACT', 'email': 'martina.montero@avacare.com'}, {'name': 'Kenneth Steil', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ctr Dermatology and Plastic Surgery', 'geoPoint': {'lat': 33.50921, 'lon': -111.89903}}, {'zip': '95438', 'city': 'Fremont', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Natalya Likhareva', 'role': 'CONTACT', 'email': 'natalyal@ctr4derm.com', 'phone': '510-797-0140'}, {'name': 'Sunil Dhawan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ctr for Dermatology Clinical Res', 'geoPoint': {'lat': 37.54827, 'lon': -121.98857}}, {'zip': '90033', 'city': 'Los Angeles', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Kenan Kherallah', 'role': 'CONTACT', 'email': 'kenan.kherallah@med.usc.edu'}, {'name': 'Katrina Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'USC Keck School of Medicine', 'geoPoint': {'lat': 34.05223, 'lon': -118.24368}}, {'zip': '92103', 'city': 'San Diego', 'state': 'California', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'role': 'CONTACT', 'phone': '619-542-0013'}, {'name': 'Michelle Pelle', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'MedDerm Associates', 'geoPoint': {'lat': 32.71571, 'lon': -117.16472}}, {'zip': '33134', 'city': 'Coral Gables', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Emma Fuentez', 'role': 'CONTACT', 'email': 'efuentez@ccstexas.com'}, {'name': 'Javier Alonso Llamazares', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Driven Research', 'geoPoint': {'lat': 25.72149, 'lon': -80.26838}}, {'zip': '33179', 'city': 'Miami', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Denys Menendez', 'role': 'CONTACT', 'email': 'dmenendez@floridianresearch.com'}, {'name': 'Gretel Trullenque', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Floridian Research Institute', 'geoPoint': {'lat': 25.77427, 'lon': -80.19366}}, {'zip': '34239', 'city': 'Sarasota', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Emily Swede', 'role': 'CONTACT', 'email': 'Emily@arthritiscenters.net', 'phone': '941-366-1244'}, {'name': 'Jesse Boodoo', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Sarasota Arthritis Res Ctr', 'geoPoint': {'lat': 27.33643, 'lon': -82.53065}}, {'zip': '33612', 'city': 'Tampa', 'state': 'Florida', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jarriaun Streets', 'role': 'CONTACT', 'email': 'jstreets@usf.edu', 'phone': '813-974-6378'}, {'name': 'Ann Lin', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'University Of South Florida', 'geoPoint': {'lat': 27.94752, 'lon': -82.45843}}, {'zip': '30303', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jazmine Stokes', 'role': 'CONTACT', 'email': 'jazmine.stokes@emory.edu'}, {'name': 'Lauren Orenstein', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Emory School of Med Dermatology', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '30331', 'city': 'Atlanta', 'state': 'Georgia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Chioma Maduoma', 'role': 'CONTACT', 'email': 'research@divinedermatl.com'}, {'name': 'Tunisia Cornelius', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Atlanta Biomedical Clin Res LLC', 'geoPoint': {'lat': 33.749, 'lon': -84.38798}}, {'zip': '60611', 'city': 'Chicago', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Sally Canter', 'role': 'CONTACT', 'email': 'sally.canter@northwestern.edu'}, {'name': 'Kelsey Flood', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Northwestern University', 'geoPoint': {'lat': 41.85003, 'lon': -87.65005}}, {'zip': '60077', 'city': 'Glenview', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jalen Corey', 'role': 'CONTACT', 'email': 'jcorey@northshore.org'}, {'name': 'Shannon Ewing', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Endeavor Health', 'geoPoint': {'lat': 42.06975, 'lon': -87.78784}}, {'zip': '60118', 'city': 'West Dundee', 'state': 'Illinois', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Paul Getz', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Dundee Dermatology', 'geoPoint': {'lat': 42.09808, 'lon': -88.28286}}, {'zip': '47150', 'city': 'New Albany', 'state': 'Indiana', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Mariah Linton', 'role': 'CONTACT', 'email': 'mlinton@soinct.com'}, {'name': 'Megan Landis', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Southern IN Clinical Trials', 'geoPoint': {'lat': 38.28562, 'lon': -85.82413}}, {'zip': '02215', 'city': 'Boston', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Hoang Truong', 'role': 'CONTACT', 'email': 'htruong1@bidmc.harvard.edu', 'phone': '617-667-7000'}, {'name': 'Alexa B Kimball', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Beth Israel Deaconess Med Center', 'geoPoint': {'lat': 42.35843, 'lon': -71.05977}}, {'zip': '02135', 'city': 'Brighton', 'state': 'Massachusetts', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Grace Zhang', 'role': 'CONTACT', 'email': 'gzhang@metrobostoncp.com', 'phone': '617-783-7100'}, {'name': 'Mark Amster', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Metro Boston Clinical Partners', 'geoPoint': {'lat': 42.3501, 'lon': -71.15644}}, {'zip': '48047', 'city': 'Chesterfield', 'state': 'Michigan', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Karie Simons', 'role': 'CONTACT', 'email': 'ksimons@researchmi.com'}, {'name': 'Natalia Filipof', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Clinical Research Inst of MI', 'geoPoint': {'lat': 42.66281, 'lon': -82.84242}}, {'zip': '63117', 'city': 'St Louis', 'state': 'Missouri', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Cliethia Raymond', 'role': 'CONTACT', 'email': 'cliethia@gmail.com'}, {'name': 'Duane Dilworth', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Deluxe Dermatology', 'geoPoint': {'lat': 38.62727, 'lon': -90.19789}}, {'zip': '68144', 'city': 'Omaha', 'state': 'Nebraska', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Samantha Jo Johnson', 'role': 'CONTACT', 'email': 'sam.johnson@lovelyskin.com', 'phone': '402-334-7546'}, {'name': 'Joel Schlessinger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Skin Specialists PC', 'geoPoint': {'lat': 41.25626, 'lon': -95.94043}}, {'zip': '89119', 'city': 'Las Vegas', 'state': 'Nevada', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Victoria Farley', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Vivida Dermatology', 'geoPoint': {'lat': 36.17497, 'lon': -115.13722}}, {'zip': '11040', 'city': 'New Hyde Park', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Kirendra Pasram', 'role': 'CONTACT', 'email': 'kpasram1@northwell.edu', 'phone': '516-719-3376'}, {'name': 'Amit Garg', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'North Shore University Hospital', 'geoPoint': {'lat': 40.7351, 'lon': -73.68791}}, {'zip': '10023', 'city': 'New York', 'state': 'New York', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Shanzida Refa', 'role': 'CONTACT', 'email': 'srefa@equity-med.com'}, {'name': 'Michael Cameron', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Cameron Dermatology', 'geoPoint': {'lat': 40.71427, 'lon': -74.00597}}, {'zip': '44512', 'city': 'Boardman', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Carol Lovash', 'role': 'CONTACT', 'email': 'clovash@optimatrials.com'}, {'name': 'Patrick Shannon', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Optima Research Boardman', 'geoPoint': {'lat': 41.02423, 'lon': -80.66285}}, {'zip': '43210', 'city': 'Columbus', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Elizabeth Gingery', 'role': 'CONTACT', 'email': 'elizabeth.gingery@osumc.edu', 'phone': '614-293-4434'}, {'name': 'Jessica Kaffenberger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Ohio State University', 'geoPoint': {'lat': 39.96118, 'lon': -82.99879}}, {'zip': '45324', 'city': 'Fairborn', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'James Jim Studebaker', 'role': 'CONTACT', 'email': 'james.studebaker@wspi.org', 'phone': '937-245-7500'}, {'name': 'Craig Rohan', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Wright State University', 'geoPoint': {'lat': 39.82089, 'lon': -84.01938}}, {'zip': '44124', 'city': 'Mayfield Heights', 'state': 'Ohio', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jane Boggan', 'role': 'CONTACT', 'email': 'jboggan@apexskin.com'}, {'name': 'Jorge Garcia-Zuazaga', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Apex Clinical Research Center LLC', 'geoPoint': {'lat': 41.51922, 'lon': -81.4579}}, {'zip': '29407', 'city': 'Charleston', 'state': 'South Carolina', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Amber Thompson', 'role': 'CONTACT', 'email': 'amber.thompson@dermandlaser.com', 'phone': '843-556-8886'}, {'name': 'Todd Schlesinger', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Clinical Research Ctr of Carolinas', 'geoPoint': {'lat': 32.77632, 'lon': -79.93275}}, {'zip': '37072-2301', 'city': 'Goodlettsville', 'state': 'Tennessee', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Mary Smith', 'role': 'CONTACT', 'email': 'mary.smith@objective.health', 'phone': '615-859-0900'}, {'name': 'Keith H Loven', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Goodlettsville Dermatology Research', 'geoPoint': {'lat': 36.32311, 'lon': -86.71333}}, {'zip': '77346', 'city': 'Humble', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Irene Noblitt', 'role': 'CONTACT', 'email': 'inoblitt@accurateclinicalmanagement.com'}, {'name': 'Chinelo Fangtang', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Accurate Clinical Research', 'geoPoint': {'lat': 29.99883, 'lon': -95.26216}}, {'zip': '78660', 'city': 'Pflugerville', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Tommy Ha', 'role': 'CONTACT', 'email': 'tha@atxresearch.com', 'phone': '512-259-2545'}, {'name': 'Edward Lain', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Austin Inst for Clinical Research', 'geoPoint': {'lat': 30.43937, 'lon': -97.62}}, {'zip': '77598', 'city': 'Webster', 'state': 'Texas', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Rosalva Duran', 'role': 'CONTACT', 'email': 'rduran@ccstexas.com', 'phone': '281-333-2288'}, {'name': 'Patricia C Lee', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Center for Clinical Studies-Lee', 'geoPoint': {'lat': 29.53773, 'lon': -95.11826}}, {'zip': '22206', 'city': 'Arlington', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Lakeesha Kosh', 'role': 'CONTACT', 'email': 'lakeesha.kosh@careaccess.com'}, {'name': 'David Bray', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Care Access Alexandria', 'geoPoint': {'lat': 38.88101, 'lon': -77.10428}}, {'zip': '24541', 'city': 'Danville', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Melissa Andrade', 'role': 'CONTACT', 'email': 'melissa.andrade@careaccess.com'}, {'name': 'Keith Robinson', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Complexions Dermatology', 'geoPoint': {'lat': 36.58597, 'lon': -79.39502}}, {'zip': '22182', 'city': 'Vienna', 'state': 'Virginia', 'status': 'RECRUITING', 'country': 'United States', 'contacts': [{'name': 'Jennifer Peters', 'role': 'CONTACT', 'email': 'jennifer.peters@forefrontderm.com'}, {'name': 'Naiem Issa', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Forefront Dermatology', 'geoPoint': {'lat': 38.90122, 'lon': -77.26526}}, {'zip': 'C1012AAY', 'city': 'CABA', 'status': 'RECRUITING', 'country': 'Argentina', 'facility': 'Novartis Investigative Site'}, {'zip': 'C1205AAO', 'city': 'Caba', 'status': 'RECRUITING', 'country': 'Argentina', 'facility': 'Novartis Investigative Site'}, {'zip': 'B5000', 'city': 'Córdoba', 'status': 'RECRUITING', 'country': 'Argentina', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': -31.40648, 'lon': -64.18853}}, {'zip': '4020', 'city': 'Linz', 'status': 'RECRUITING', 'country': 'Austria', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 48.30639, 'lon': 14.28611}}, {'zip': '1070', 'city': 'Brussels', 'status': 'RECRUITING', 'country': 'Belgium', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.85045, 'lon': 4.34878}}, {'zip': '3000', 'city': 'Leuven', 'status': 'RECRUITING', 'country': 'Belgium', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.87959, 'lon': 4.70093}}, {'zip': '4000', 'city': 'Liège', 'status': 'RECRUITING', 'country': 'Belgium', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.63373, 'lon': 5.56749}}, {'zip': 'B 1200', 'city': 'Woluwe-Saint-Lambert', 'status': 'RECRUITING', 'country': 'Belgium', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.84389, 'lon': 4.42912}}, {'zip': 'T6G 1C3', 'city': 'Edmonton', 'state': 'Alberta', 'status': 'RECRUITING', 'country': 'Canada', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 53.55014, 'lon': -113.46871}}, {'zip': 'N6H 5L5', 'city': 'London', 'state': 'Ontario', 'status': 'RECRUITING', 'country': 'Canada', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 42.98339, 'lon': -81.23304}}, {'zip': 'H1Y 3L1', 'city': 'Montreal', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 45.50884, 'lon': -73.58781}}, {'zip': 'G1V 4T3', 'city': 'Québec', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 46.81228, 'lon': -71.21454}}, {'zip': 'J1G 1X9', 'city': 'Sherbrooke', 'state': 'Quebec', 'status': 'RECRUITING', 'country': 'Canada', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 45.40008, 'lon': -71.89908}}, {'zip': '050010', 'city': 'Medellín', 'state': 'Antioquia', 'status': 'RECRUITING', 'country': 'Colombia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 6.245, 'lon': -75.57151}}, {'zip': '110110', 'city': 'Bogota', 'state': 'Cundinamarca', 'status': 'RECRUITING', 'country': 'Colombia', 'facility': 'Novartis Investigative Site'}, {'zip': '111411', 'city': 'Bogota', 'state': 'Cundinamarca', 'status': 'RECRUITING', 'country': 'Colombia', 'facility': 'Novartis Investigative Site'}, {'zip': '050012', 'city': 'Medellín', 'status': 'RECRUITING', 'country': 'Colombia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 6.245, 'lon': -75.57151}}, {'zip': '360 01', 'city': 'Karlovy Vary', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.23271, 'lon': 12.87117}}, {'zip': '32300', 'city': 'Plzen Bolevec', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site'}, {'zip': '100 34', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '120 00', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '128 08', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '150 06', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '180 81', 'city': 'Prague', 'status': 'RECRUITING', 'country': 'Czechia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 50.08804, 'lon': 14.42076}}, {'zip': '29609', 'city': 'Brest', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 48.39029, 'lon': -4.48628}}, {'zip': '17019', 'city': 'La Rochelle', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 46.16308, 'lon': -1.15222}}, {'zip': '69003', 'city': 'Lyon', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 45.74906, 'lon': 4.84789}}, {'zip': '06000', 'city': 'Nice', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 43.70313, 'lon': 7.26608}}, {'zip': '51100', 'city': 'Reims', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 49.26526, 'lon': 4.02853}}, {'zip': '76031', 'city': 'Rouen', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 49.44313, 'lon': 1.09932}}, {'zip': '31400', 'city': 'Toulouse', 'status': 'RECRUITING', 'country': 'France', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 43.60426, 'lon': 1.44367}}, {'zip': '79106', 'city': 'Freiburg im Breisgau', 'state': 'Baden-Wurttemberg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 47.9959, 'lon': 7.85222}}, {'zip': '97080', 'city': 'Würzburg', 'state': 'Bavaria', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 49.79391, 'lon': 9.95121}}, {'zip': '40225', 'city': 'Düsseldorf', 'state': 'North Rhine-Westphalia', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.22172, 'lon': 6.77616}}, {'zip': '66663', 'city': 'Merzig', 'state': 'Saarland', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 49.44331, 'lon': 6.63874}}, {'zip': '04103', 'city': 'Leipzig', 'state': 'Saxony', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.33962, 'lon': 12.37129}}, {'zip': '48455', 'city': 'Bad Bentheim', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.30066, 'lon': 7.15763}}, {'zip': '13595', 'city': 'Berlin', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.52437, 'lon': 13.41053}}, {'zip': '06847', 'city': 'Dessau', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.83864, 'lon': 12.24555}}, {'zip': '44137', 'city': 'Dortmund', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.51494, 'lon': 7.466}}, {'zip': '45147', 'city': 'Essen', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.45657, 'lon': 7.01228}}, {'zip': '20246', 'city': 'Hamburg', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 53.55073, 'lon': 9.99302}}, {'zip': '23538', 'city': 'Lübeck', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 53.86893, 'lon': 10.68729}}, {'zip': '32429', 'city': 'Minden', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.28953, 'lon': 8.91455}}, {'zip': '80377', 'city': 'München', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.60698, 'lon': 13.31243}}, {'zip': '72076', 'city': 'Tübingen', 'status': 'RECRUITING', 'country': 'Germany', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 48.52266, 'lon': 9.05222}}, {'zip': '161 21', 'city': 'Athens', 'status': 'RECRUITING', 'country': 'Greece', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 37.98376, 'lon': 23.72784}}, {'zip': '124 62', 'city': 'Chaïdári', 'status': 'RECRUITING', 'country': 'Greece', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 38.01135, 'lon': 23.66597}}, {'zip': '564 03', 'city': 'Thessaloniki', 'status': 'RECRUITING', 'country': 'Greece', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 40.64072, 'lon': 22.93493}}, {'zip': '4032', 'city': 'Debrecen', 'state': 'Hajdu Bihar Megye', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 47.53167, 'lon': 21.62444}}, {'zip': '1036', 'city': 'Budapest', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'zip': 'H-1083', 'city': 'Budapest', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 47.49835, 'lon': 19.04045}}, {'zip': '6001', 'city': 'Kecskemét', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 46.90618, 'lon': 19.69128}}, {'zip': '7623', 'city': 'Pécs', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 46.07617, 'lon': 18.22814}}, {'zip': '6720', 'city': 'Szeged', 'status': 'RECRUITING', 'country': 'Hungary', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 46.253, 'lon': 20.14824}}, {'zip': '50586', 'city': 'Kuala Lumpur', 'state': 'Kuala Lumpur', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 3.1412, 'lon': 101.68653}}, {'zip': '30450', 'city': 'Ipoh', 'state': 'Perak', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 4.5841, 'lon': 101.0829}}, {'zip': '88586', 'city': 'Kota Kinabalu', 'state': 'Sabah', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 5.9749, 'lon': 116.0724}}, {'zip': '80100', 'city': 'Johor Bahru', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 1.4655, 'lon': 103.7578}}, {'zip': '68100', 'city': 'Selangor Darul Ehsan', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site'}, {'zip': '62502', 'city': 'Wilayah Persekutuan', 'status': 'RECRUITING', 'country': 'Malaysia', 'facility': 'Novartis Investigative Site'}, {'zip': '02-953', 'city': 'Warsaw', 'state': 'Masovian Voivodeship', 'status': 'RECRUITING', 'country': 'Poland', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '02-507', 'city': 'Warsaw', 'status': 'RECRUITING', 'country': 'Poland', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '02-962', 'city': 'Warsaw', 'status': 'RECRUITING', 'country': 'Poland', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 52.22977, 'lon': 21.01178}}, {'zip': '00985', 'city': 'Carolina', 'status': 'RECRUITING', 'country': 'Puerto Rico', 'contacts': [{'name': 'Sandra Ortiz', 'role': 'CONTACT', 'email': 'syokas5@hotmail.com', 'phone': '+1 787 769 1954'}, {'name': 'Alma Cruz', 'role': 'PRINCIPAL_INVESTIGATOR'}], 'facility': 'Alma Cruz-Santana Private Practice', 'geoPoint': {'lat': 18.38078, 'lon': -65.95739}}, {'zip': '020125', 'city': 'Bucharest', 'state': 'District 2', 'status': 'RECRUITING', 'country': 'Romania', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'zip': '020762', 'city': 'Bucharest', 'state': 'District 2', 'status': 'RECRUITING', 'country': 'Romania', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 44.43225, 'lon': 26.10626}}, {'zip': '18014', 'city': 'Granada', 'state': 'Andalusia', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 37.18817, 'lon': -3.60667}}, {'zip': '41009', 'city': 'Seville', 'state': 'Andalusia', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 37.38283, 'lon': -5.97317}}, {'zip': '07120', 'city': 'Palma', 'state': 'Balearic Islands', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 39.56939, 'lon': 2.65024}}, {'zip': '08041', 'city': 'Barcelona', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 41.38879, 'lon': 2.15899}}, {'zip': '08402', 'city': 'Granollers', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 41.60797, 'lon': 2.28773}}, {'zip': '35010', 'city': 'Las Palmas GC', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site'}, {'zip': '28006', 'city': 'Madrid', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '28041', 'city': 'Madrid', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 40.4165, 'lon': -3.70256}}, {'zip': '36003', 'city': 'Pontevedra', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 42.431, 'lon': -8.64435}}, {'zip': '46026', 'city': 'Valencia', 'status': 'RECRUITING', 'country': 'Spain', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 39.47391, 'lon': -0.37966}}, {'zip': '35340', 'city': 'Izmir', 'state': 'Balcova', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'zip': '06800', 'city': 'Ankara', 'state': 'Bilkent-Cankaya', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 39.91987, 'lon': 32.85427}}, {'zip': '35390', 'city': 'Izmir', 'state': 'Buca', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'zip': '09100', 'city': 'Aydin', 'state': 'Efeler', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 37.84501, 'lon': 27.83963}}, {'zip': '06230', 'city': 'Ankara', 'state': 'Sihhiye-Altindag', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 39.91987, 'lon': 32.85427}}, {'zip': '06500', 'city': 'Ankara', 'state': 'Yenimahalle', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 39.91987, 'lon': 32.85427}}, {'zip': '33110', 'city': 'Mersin', 'state': 'Yenisehir', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 36.81196, 'lon': 34.63886}}, {'zip': '35100', 'city': 'Izmir', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 38.41273, 'lon': 27.13838}}, {'zip': '34688', 'city': 'Üsküdar', 'status': 'RECRUITING', 'country': 'Turkey (Türkiye)', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 41.02274, 'lon': 29.01366}}, {'zip': 'CF14 4XW', 'city': 'Cardiff', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.48, 'lon': -3.18}}, {'zip': 'SE5 9RS', 'city': 'London', 'status': 'RECRUITING', 'country': 'United Kingdom', 'facility': 'Novartis Investigative Site', 'geoPoint': {'lat': 51.50853, 'lon': -0.12574}}], 'centralContacts': [{'name': 'Novartis Pharmaceuticals', 'role': 'CONTACT', 'email': 'novartis.email@novartis.com', 'phone': '1-888-669-6682'}, {'name': 'Novartis Pharmaceuticals', 'role': 'CONTACT', 'email': 'novartis.email@novartis.com', 'phone': '+41613241111'}], 'overallOfficials': [{'name': 'Novartis Pharmaceuticals', 'role': 'STUDY_DIRECTOR', 'affiliation': 'Novartis Pharmaceuticals'}]}, 'ipdSharingStatementModule': {'ipdSharing': 'YES', 'description': 'Novartis is committed to sharing with qualified external researchers, access to patient-level data and supporting clinical documents from eligible studies. These requests are reviewed and approved by an independent review panel on the basis of scientific merit. All data provided is anonymized to respect the privacy of patients who have participated in the trial in line with applicable laws and regulations.\n\nThis trial data availability is according to the criteria and process described on www.clinicalstudydatarequest.com'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Novartis Pharmaceuticals', 'class': 'INDUSTRY'}, 'responsibleParty': {'type': 'SPONSOR'}}}}